The unified social credit code/registration number of Tianjin Taihe Pharmaceutical Co., Ltd. is 9110560058525xd, and the enterprise is in the opening state.
The business scope of Tianjin Taihe Pharmaceutical Co., Ltd. is: the production of freeze-dried powder injections (including anti-tumor drugs), hard capsules (including anti-tumor drugs) and raw materials (boanmycin hydrochloride, nimodipine hydrochloride, formostatin, tegafur, fluorouracil, mitoxantrone hydrochloride, vitamin B2 and Pingyangmycin hydrochloride); Office supplies and daily necessities wholesale and retail. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Tianjin, the total registered capital of companies with similar business scope is 2,309.37 million yuan, and the main capital is concentrated in enterprises with a scale of over 50 million, including *** 1 1. In the province, the registered capital of enterprises is excellent.
Tianjin Taihe Pharmaceutical Co., Ltd. invested 1 company and 0 branches.
See more information and materials of Tianjin Taihe Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.